Tectonic Therapeutic to Participate in December Investor Conferences

Rhea-AI Summary

Tectonic Therapeutic (NASDAQ: TECX) announced management will participate in two investor conferences in December 2025. Key events: a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on December 2, 2025 at 3:30 PM ET in New York with Alise Reicin, MD, President and CEO, and one-on-one investor meetings at the Evercore 8th Annual Healthcare Conference on December 3, 2025 in Miami.

The Piper Sandler session will be webcast and available under the company’s Investors “Events & Presentations” page at www.tectonictx.com, with a replay accessible for approximately 90 days. Investors should contact their Piper Sandler or Evercore representatives to request one-on-one meetings.

WATERTOWN, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced that company management will participate in two upcoming investor conferences taking place in December 2025.

Piper Sandler 37^th Annual Healthcare Conference

Date: Time: Location: Format: Presenters: Webcast:

December 2, 2025 3:30 PM EST New York, NY Fireside Chat Alise Reicin, MD, President and Chief Executive Officer Link

Evercore 8^th Annual Healthcare Conference

Date: Location: Format:

December 3, 2025 Miami, FL Investor Meetings

The live fireside chat can also be accessed under “Events & Presentations” on the Investors section of the Tectonic website at www.tectonictx.com. A replay of the webcast will be available on the Company’s website for approximately 90 days.

The Tectonic management team will host one-on-one meetings during the two conferences. Interested investors should contact their Piper Sandler and Evercore representatives to schedule meetings.

About Tectonic
Tectonic Therapeutic is a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Leveraging its proprietary technology platform called GEODe™ (GPCRs Engineered for Optimal Discovery), Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery and harness the human body to modify the course of disease. Tectonic focuses on areas of significant unmet medical need, often where therapeutic options are poor or nonexistent, as these are areas where new medicines have the potential to improve patient quality of life. Tectonic is headquartered in Watertown, Massachusetts. For more information, please visit www.tectonictx.com and follow us on LinkedIn.

Contacts:

Investors:
Dan Ferry
LifeSci Advisors
(617) 430-7576
daniel@lifesciadvisors.com

Media:
Kathryn Morris
The Yates Network
(914) 204-6412
kathryn@theyatesnetwork.com

FAQ

When will Tectonic Therapeutic (TECX) present at the Piper Sandler Healthcare Conference in December 2025?

Tectonic will hold a fireside chat on December 2, 2025 at 3:30 PM ET in New York.

Who will represent Tectonic Therapeutic (TECX) at the December 2, 2025 Piper Sandler fireside chat?

Alise Reicin, MD, President and Chief Executive Officer, will participate in the fireside chat.

Will the Piper Sandler fireside chat for Tectonic Therapeutic (TECX) be available online and for how long?

Yes; the live webcast is on the company Investors “Events & Presentations” page and a replay will be available for about 90 days.

When and where will Tectonic Therapeutic (TECX) hold investor meetings at Evercore in December 2025?

Tectonic management will host one-on-one investor meetings at the Evercore conference on December 3, 2025 in Miami.

How can investors schedule one-on-one meetings with Tectonic Therapeutic (TECX) at the December 2025 conferences?

Interested investors should contact their Piper Sandler or Evercore representatives to schedule meetings.